Benign Prostatic Hyperplasia Human Prostate Tissue Genomic DNA, Donor 645 (CAT#: DBFF-0624-HY1841)

Datasheet

Overview

Benign prostatic hyperplasia is a common problem of male urinary system. It is caused by an overgrowth of prostate tissue, which often leads to symptoms such as difficulty urinating, frequent urination and urgency. Benign Prostatic Hyperplasia Human Prostate Tissue Genomic DNA, Donor 645 is a highly pure intact high molecular size DNA. It is extracted from prostate tissue of benign prostatic hyperplasia human donor and treated with DNase-free RNase to remove contaminant RNA. Its purity and intactness make it an ideal choice for researchers seeking reliable and accurate data in their genetic research.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Male

Age At Sampling

56 yrs

Race

White or Caucasian

Medical Diagnosis

Adenocarcinoma of prostate

Product Description

Species

Human

Tissue Name

Prostate

Sample Diagnosis Category

Benign Prostatic Hyperplasia

28S/18S Ratio

2.03

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Southern blot analysis, polymerase chain reaction amplification, genomic DNA methylation, single nucleotide polymorphism analysis, profiling studies in gene expression, and DNA library construction.

Product Properties

Normal Ratio

Lesional Ratio

100%

Tumor Ratio

Hypocellular/Acellular Tumor Stroma Ratio

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

H&E Staining Pathological Verification

70% epithelium, 30% fibromuscular stroma; Lesion: 95% benign hyperplasia of prostate, 5% prostatitis

Histopathological Grade

Gleason Score: 3+3=6/10

Tumor Stage

Primary Tumor (T)

T2b

Regional Lymph Node (N)

Distant Metastasis (M)

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use